PKC-mediated vesicular release provides a target for potential therapeutic interventions to modulate mechano-responsiveness and mechano-resilience in humans habitually experiencing altered mechanical environment, such as astronauts or paralysis patients. This evidence concerns the gene PRRT2 and Paralysis.